Analystreport

TCR2 Therapeutics Inc. (NASDAQ: TCRR) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating.

TCR2 Therapeutics Inc.  (TCRR) 
Last tcr2 therapeutics inc. earnings: 11/12 07:00 am Check Earnings Report